Publications

Choksi NY, Waller CL, Booth RG. Neurotoxic and neuroprotective effects of polychlorinated biphenyls and adenosine compounds in rat brain. Presented at Society for Neuroscience Annual Meeting, San Diego, CA, November 1995.

Perry CS, Liu XL, Lund LG, Kehrer JP. 1995. Differential toxicities of cyclophosphamide and its glutathione metabolites to A549 cells. Toxicol in Vitro 9(1):21-26; doi: 10.1016/0887-2333(94)00187-Y.

Norton JN, Rylander LA, Richards JL. 1995. In vitro oral mucosa irritation testing with human cell cultures. Toxicol In Vitro 9(1):67–74; 10.1016/0887-2333(94)00189-2.

Prioleau C, Montague DM, Choksi NY, Southerland SB, Lawler CP, Mailman RB. Unusual neurochemical properties of the novel antipsychotic OPC-14597 in rat striatum. Poster presented at Society for Neuroscience Annual Meeting, 1995.

Covington TR, Gearhart JM, Clewell HJ. A physiologically based pharmacokinetic (PBPK) model for 133Xe and 222Rn in the human. Poster presented at the Society of Toxicology Annual Meeting, Baltimore, MD, March 1995.

Haws L. How are we implementing the combustion strategy and indirect risk assessment? Presented at the Texas Natural Resource Conservation Commission Hazardous Waste Seminar, Houston, TX, October 1994.

Gargas M, Norton R, Harris MA, Paustenbach D, Finley B. 1994. Urinary excretion of chromium following ingestion of chromite ore processing residue in humans: Implications for biomonitoring. Risk Anal 14(6):1019-1024; doi: 10.1111/j.1539-6924.1994.tb00071.x.

Haws L. Indirect risk assessment. Presented at the Sixth Annual Texas Environmental Superconference, Austin, TX, August 1994.

Haws LC, Jackson BA, Turnbull D, Dressler WE. 1994. Two approaches for assessing human cancer risk from disperse blue 1. Regul Toxicol Pharmacol. 19(1):80-96; doi: 10.1006/rtph.1994.1007.

Haws L. Overview of TNRCC/EPA concerns, strategies, and schedules concerning indirect risk assessment requirements. Presented at the Workshop on Risk Assessment and Waste Incineration Facilities. Houston, TX, June 28, 1994 and Austin, TX, June 29, 1994.

Haws L. Indirect risk workshop. Panel Discussant. Presented at the RCRA Policy Forum, Washington, DC, January 1994.

Haws L. Keynote Address. Presented at the DRE Environmental Services Workshop on EPA’s New Policy of Hazardous Waste Combustion, Austin, TX, January 1994.

Rish W. 1994. SEC initiatives in environmental disclosure: How can environmental liability be estimated? Ohio Environmental Law Letter 4(6):3–4.

Choksi NY, Hussain A, Owens CE, Myers AM, Harvey RD, Baldessarini RJ, Wyrick SD, Booth RG. Adenosine A2 and PAT- σ3 agonists affect adenylyl cyclase activity and dopamine synthesis. Poster presented at North Carolina Society for Neuroscience Meeting, 1994.

Choksi NY, Hussain A, Myers AM, Owens CE, Harvey RD, Wyrick SD, Baldessarini RJ, Booth RG. Stimulation of brain cAMP and dopamine synthesis by adenosine A2 and σ3 agonists. Poster presented at Society for Neuroscience Annual Meeting, 1994

Sahl JD, Kelsh MA, Smith RW, Aseltine DA. 1994. Exposure to 60 Hz magnetic fields in the electric utility work environment. Bioelectromag 15(1):21-32; doi: 10.1002/bem.2250150107.

Haws, L. Principles of toxicology and risk assessment. Presented at the University of Texas at Austin LBJ School of Public Affairs, Austin, TX, September 1993.

Cohan S, Redman D, Chen M, Wilson D, Cyr PL. 1993. Flunarazine blocks elevation of free cytosolic calcium in synaptosomes following sustained depolarization. J Cereb Blood Flow Metab 13(6):947-953; doi: 10.1038/jcbfm.1993.118.

Sahl JD, Kelsh MA, Greenland S. 1993. Cohort and nested case-control studies of hematopoietic cancers and brain cancer among electric utility workers. Epidemiol 4(2):104-114; doi: 10.1097/00001648-199303000-00005.

Haws, L. Developmental toxicity of TCDD and related compounds. Presented at the Texas A&M University Faculty of Toxicology Seminar Series, College Station, TX, October 1992.